Synthetic Biologics, Inc. SYN Cash Flow

Synthetic biologics, inc. (SYN)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash Flows From Operating Activities:
Net loss
-2,990	-3,144	-5,150	-3,558	-3,528	-3,192	-3,689	-4,214	-2,326	2,812	-10,931	-4,315	-3,058	-2,472	-8,489	-5,764	-11,078	-11,297	-7,507	-13,623	-12,358	-6,480	-4,910	-4,556	-3,838	-4,225	-3,368	-2,497	-2,228	-	-	-	-	-	-	-	-
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,930	-1,872	-1,200	-	-	-	-
Adjustments to reconcile net loss to net cash used in operating activities:
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,223
Net income from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37
Stock-based compensation
83	94	91	91	64	366	475	557	676	503	900	871	1,135	1,103	947	907	1,052	1,139	646	586	827	632	610	855	362	467	338	407	457	548	395	400	508	490	56	-341	768
Subsidiary stock issued to consultant
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Subsidiary stock issues to vendor
26	-	-	-	16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant issued to vendor
-	-	-	-	-	0	0	0	9	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock issued for milestone payments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-1,000	-350	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Stock issued as compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	76
Stock issued for consulting fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	107	0	58
Change in fair value of warrant liabilities
-	-	-	-	-	-19	-626	-783	-2,655	-8,581	5,092	-2,159	-5,090	-7,731	-666	-3,513	498	-95	-4,141	3,895	4,152	-620	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation
58	58	60	60	62	65	66	70	71	73	56	59	57	46	54	20	37	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	776	716
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	164	-16	94
Depreciation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20	11	8	-	6	4	3	-	10	12	11	12	12	19	20	11	32	21	80
Provision for uncollectible note and interest receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	157	8	160	66	167	21
Changes in operating assets and liabilities:
Gain on the settlement of accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	63
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-19	-38	43	69	116	184	111
Prepaid expenses and other current assets
-297	188	-106	439	267	34	24	-71	-221	-437	-276	-1,826	851	-576	-2,683	-1,342	-2,403	-812	3,376	5,381	26	166	-7	57	-259	-55	-171	-354	-275	2,409	57	11	67	-	-	-	-
Right of use asset
33	32	30	28	28	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other current assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	48	0	-268
Note receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Deposits and other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-3	1	-1	12	0	-4	0	12	0	0	0	2	0	-11	0	-22	10	7	-1	-10	-2	-8	18	-68
Gain on discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	677	-	-	-	-
Assets of discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3	3
Accounts payable
-1,068	-137	929	757	-267	154	-338	-276	-527	922	-624	-2,074	1,803	-2,249	-314	-41	184	-1,613	-2,660	7,127	563	123	-206	306	631	-442	371	17	-199	5	112	-38	-72	193	-94	-100	154
Accrued expenses
-714	-546	776	-84	711	-566	485	-58	-468	-544	320	-384	-493	1,137	-350	894	649	53	-1,371	-1,031	1,348	1,190	-42	-732	0	885	-16	16	0	-27	-90	-10	98	-12	18	5	-192
Accrued employee benefits
-626	316	108	170	-991	-102	71	347	-1,058	468	397	422	474	-1,027	166	305	592	-37	-80	166	-310	535	0	885	-885	-	-	-	-	-	-	-	-	-	-	-	-
Lease liability
-59	-58	-54	-53	-52	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
-	-	-	-	-	-24	-22	-22	-22	-22	-10	14	15	230	-13	-11	1	35	253	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	-5
Liabilities of discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-16	40
Net Cash Used In Operating Activities
-4,960	-3,605	-3,062	-2,982	-4,224	-3,290	-3,602	-4,308	-6,079	-3,932	-4,524	-5,740	-6,008	-10,384	-5,983	-5,860	-5,674	-	-	-	-	-4,779	-4,535	-3,295	-3,470	-	-	-	-	-4,773	-1,442	-1,286	-1,415	-731	-911	-952	-281
Cash Flows From Investing Activities:
Net Cash Used In Operating Activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-15,212	-7,250	-5,458	-	-	-	-	-	-1,720	-1,633	-1,662	-	-	-	-	-	-	-	-
Purchases of property and equipment
-	-	-	-	-	-	-	-	-	3	198	0	11	370	154	1	44	44	396	43	18	5	22	17	4	11	12	10	3	3	7	0	0	-	-	-	-
Proceeds from the sale of equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	0	0	1
Net Cash From Investing Activities
0	0	0	0	0	-7	0	0	0	-3	-198	0	-11	-370	-154	-1	-44	-	-	-	-	-5	-22	-17	-4	-	-	-	-	-3	-7	0	0	2,790	-2,866	0	1
Cash Flows From Financing Activities:
Proceeds from issuance of common stock for stock option exercises
-	-	-	-	-	-	-	-	-	-	0	0	166	0	4	810	0	-	-	-	-	0	0	0	4	1	0	0	231	-	-	-	-	-	-	-	-
Proceeds from "at the market" stock issuance
-	-	-	-	-	-	-	-	-	0	444	5,645	269	876	633	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Cash Used In Investing Activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-396	-43	-18	-	-	-	-	-	-12	-10	-3	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock for stock option exercises
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	26	68	-	0	0	8
Proceeds from issuance of common stock for warrant exercises
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	94	390	1,471	-	-	-	-
Proceeds from issuance of common stock for warrant exercises
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Proceeds from issuance of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,000
Cash paid as direct offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	296
Net Cash From Financing Activities
0	0	0	0	0	22,666	6,022	400	0	1	12,396	5,645	435	25,260	637	810	0	-	-	-	-	19,023	0	0	4	-	-	-	-	10,153	94	416	1,539	10	0	3,257	3,712
Net decrease in cash and cash equivalents
-4,960	-3,605	-3,062	-2,982	-4,224	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Cash Provided By Financing Activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	231	-	-	-	-	-	-	-	-
Net increase (decrease) in cash
-	-	-	-	-	-	-	-	-	-3,934	7,674	-95	-5,584	14,506	-5,500	-5,051	-5,718	-10,988	27,049	-7,292	-5,476	14,239	-4,557	-3,312	-3,470	9,480	-1,732	-1,643	-1,434	5,377	-1,355	-870	124	2,069	-3,777	2,305	3,432
Net decrease in cash and cash equivalents
-	-	-	-	-	-	-	-	-6,079	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Noncash Financing Activities:
Right of use asset from operating lease
0	-	-	-	538	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Right of use asset from operating lease
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deemed dividends for accretion of Series B Preferred Stock discount
404	-	70	117	398	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
In-kind dividends paid in preferred stock
62	63	63	61	61	62	61	61	59	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash paid for taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Series B Preferred Stock [Member]
Conversion of Series B Preferred Stock
669	-	113	187	638	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-